| Fosphenytoin - Wikipedia, the free encyclopedia Fosphenytoin (Cerebyx, Parke-Davis ; Prodilantin, Pfizer Holding France) is a water-soluble phenytoin prodrug used only in hospitals for the treatment of epileptic ... Read More |
| Fosphenytoin Official FDA information, side effects and uses. Accurate, FDA approved Fosphenytoin information for healthcare professionals and patients - brought to you by Drugs.com. Read More |
| Fosphenytoin (Cerebyx ®) - Intravenous (IV) Dilution Fosphenytoin (Cerebyx ®) The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a ... Read More |
| Fosphenytoin Facts and Comparisons at Drugs.com All about Fosphenytoin. View complete and up to date Fosphenytoin information - part of the Drugs.com trusted medication database. Read More |
| Cerebyx (Fosphenytoin Sodium Injection) Drug Information ... Learn about the prescription medication Cerebyx (Fosphenytoin Sodium Injection), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient ... Read More |
| (Fosphenytoin Sodium Injection) 1 69-5986-00-1 CEREBYX® (Fosphenytoin Sodium Injection) DESCRIPTION Cerebyx® (fosphenytoin sodium injection) is a prodrug intended for parenteral administration; Read More |
| FOSPHENYTOIN - INJECTION (Cerebyx) side effects, medical uses, and ... Consumer information about the medication FOSPHENYTOIN - INJECTION (Cerebyx), includes side effects, drug interactions, recommended dosages, and storage information. Read More |
| fosphenytoin - MSN Health - Medications Fosphenytoin is an anti-epileptic drug also called an anticonvulsant. It works by slowing down impulses in the brain that cause seizures. Fosphenytoi Read More |
| Pharmacotherapy Update | Fosphenytoin (Cerebyx®) EDITORS Marcia J. Wyman Pharm.D., BCPS Drug Information Pharmacist; Mandy C. Leonard Pharm.D., BCPS System Director, Drug Use Policy and Formulary Management Read More |
| Phenytoin and Fosphenytoin Information - U S Food and Drug ... FDA ALERT [11/24/2008] - FDA is investigating new preliminary data regarding a potential increased risk of serious skin reactions including Stevens Johnson syndrome ... Read More |
